Duke University

Overview

Duke University offers a Master of International Translational Medicine (MITM), a two-year, part-time program tailored for healthcare professionals and those involved in translational research. This program equips students with the skills to translate discoveries into real-world medical treatments, featuring expert instruction and opportunities for international networking.

What you'll study

Format: The program is structured as part-time, executive-style learning, designed to accommodate the schedules of working professionals.

Core learning areas include:

• Translational Medicine: From Unmet Need to Cure
• From Need to Target
• From Target to Treatment
• Entrepreneurship for Translational Medicine Researchers
• International Networking – Eureka Monsoon Certificate Course in Translational Medicine

Learning approach: The program emphasizes expert-led instruction, applied discussions on translational challenges, and structured learning throughout the translational pathway.

Assessment & capstone: Details regarding assessment methods are not specified. Prospective students should consult the admissions team for information on projects or exams.

Entry requirements

Applicants should possess at least a Bachelor’s degree. There is no specific requirement for GRE or GMAT scores.

Career prospects

Graduates of the Master of International Translational Medicine program will be well-prepared for advanced roles in healthcare and translational research. The comprehensive curriculum, combined with networking opportunities, positions alumni for success in various sectors, including pharmaceuticals, biotechnology, and academic research.